IRCT20190530043769N1招募中2 期
The Efficacy of Rivastigmine Augementation to Antipsychotic Agents on Positive and Negative Symptoms and Quality of Life in Patients with Chronic Schizophrenia
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with Chronic Schizophrenia
- •Patients treated with Antipsychotics
排除标准
- •IQ less than 70
- •?Another psychiatric disorder
- •Physical illness
- •ECT in the last two weeks
- •Sensitivity to Rivastigmine
研究者
相似试验
招募中
3 期
Effectiveness of Rivastigmine and Donepezil on cognitive disordersIRCT20210819052232N1Esfahan University of Medical Sciences165
已完成
2 期
The effectiveness of Rivastigmine on treatment of Tardive dyskinesiaTardive dyskinesia.Drug-induced dystoniaIRCT2012092910964N1niversity of Social Welfare and Rehabilitation Sciences40
招募中
3 期
Evaluation of the effect of rivastigmine on male patients with chronic schizophreniaIRCT20120314009297N8Mazandaran University of Medical Sciences60
招募中
3 期
Evaluation the effectiveness of rivastigmine and memantine in improving cognitive problems due to electroconvulsive therapyPsychiatric disorders with electroconvulsive therapy (ECT) indication.IRCT20190119042417N2Shahid Beheshti University of Medical Sciences45
已完成
2 期
Efficacy of rivastigmin in the treatment of major depressive disorderIRCT2017020132236N4Vice chancellor for research, Mazandaran University of Medical Sciences20